Onset and mortality of Parkinson's disease in relation to type II diabetes.
Gianni PezzoliEmanuele CeredaPaolo AmamiSanto ColosimoMichela BarichellaGiorgio SacilottoAnna ZecchinelliMichela ZiniValentina FerriCarlotta BolliriDaniela CalandrellaMaria Grazia BonelliViviana CeredaElisa RealiSerena CaronniErica CassaniMargherita CanesiFrancesca Del SorboPaola SoliveriLuigi ZeccaCatherine KlersyRoberto CiliaIoannis U IsaiasPublished in: Journal of neurology (2022)
T2D, treated with any antidiabetic therapy before PD, is associated with a delay in its onset. Duration of diabetes increases mortality in PD-preT2D, but not in PD-postT2D. These findings prompt further studies on antidiabetic drugs as a potential disease-modifying therapy for PD.